| Insider | Role | Shares | Value | Buys | Sells |
|---|---|---|---|---|---|
| Date | Ticker | Insider | Role | Type | Shares | Price | Value | Chg% | SEC |
|---|---|---|---|---|---|---|---|---|---|
| Insider | Role | Shares | Value | Buys | Sells |
|---|---|---|---|---|---|
| Date | Ticker | Insider | Role | Type | Shares | Price | Value | Chg% | SEC |
|---|---|---|---|---|---|---|---|---|---|
Chief Legal Officer
1 company
Sumer Jacquelyn L is a Chief Legal Officer at Cullinan Therapeutics, Inc.. Recent SEC Form 4 filings include 0 buys and 9 sells.
Estimated insider holdings value: $2.0M based on current market prices.
| Date | Ticker | Role | Type | Shares | Price | Value | Chg% | 3M | 12M | SEC |
|---|---|---|---|---|---|---|---|---|---|---|
| Dec 18, 2025 | CGEM Cullinan Therapeutics, Inc. | Chief Legal Officer | Sell | 3,480 | $9.67 | $33,651.60 | -2.5% | +31.6% | - | |
| Feb 25, 2025 | CGEM Cullinan Therapeutics, Inc. | Chief Legal Officer | Sell | 3,756 | $8.53 | $32,038.68 | -2.7% | -8.6% | +67.8% | |
| Dec 18, 2024 | CGEM Cullinan Therapeutics, Inc. | Chief Legal Officer | Sell | 3,482 | $11.41 | $39,729.62 | -3.7% | -17.1% | -7.3% | |
| Dec 21, 2023 | CGEM Cullinan Therapeutics, Inc. | Chief Legal Officer | Sell | 1,400 | $8.50 | $11,900.00 | -3.1% | +63.8% | +22.4% | |
| Dec 18, 2023 | CGEM Cullinan Therapeutics, Inc. | Chief Legal Officer | Sell | 290 | $8.22 | $2,383.80 | -0.6% | +67.8% | +25.8% | |
| Jun 20, 2023 | CGEM Cullinan Therapeutics, Inc. | Chief Legal Officer | Sell | 291 | $12.94 | $3,765.54 | -0.6% | -23.1% | +34.0% | |
| May 18, 2023 | CGEM Cullinan Therapeutics, Inc. | Chief Legal Officer | Sell | 291 | $8.76 | $2,549.16 | -0.6% | +13.9% | +163.3% | |
| Apr 18, 2023 | CGEM Cullinan Therapeutics, Inc. | Chief Legal Officer | Sell | 290 | $10.71 | $3,105.90 | -0.6% | +10.3% | +74.1% | |
| Mar 20, 2023 | CGEM Cullinan Therapeutics, Inc. | Chief Legal Officer | Sell | 305 | $11.32 | $3,452.60 | -0.6% | +20.1% | +42.5% |